XOMA XOMA Royalty Corporation Common Stock

XNAS 40.21 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

XOMA $40.21 —

What changed

Recent filings, trades and moves
Key stats
$40.21
52-Week Range
$22.29 – $45.22
YTD
+43.66%
IV Rank (30D)
2.21
Straddle Price
$1.52
P/C Vol Ratio (Aug 21 expiry)
12.95
Market Cap
$0.7B
Open
$43.97
Day Range
$39.77 – $43.97
Volume
6,711,917
Prev Close
$44.22
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.56%
Beta vs SPY1.00
Cost of Equity (CAPM)10.06% (VRP-adj)
WACC9.50%
Volatility Risk Premium+50.3pp (IV − HV30), ERP adj +50bps
Effective Tax Rate0.3%
Rev. Growth (YoY, DCF input)-10.0%
DCF Horizon10 years explicit + fade
Free Cash Flow (TTM)$0.0B
Return on Equity (TTM)21.5%
Book / Price11.7%
Gross Margin (TTM)100.0%
FCF Margin (TTM)5.5%
Debt / Equity1.15
Quality Score2/6 — normal (10y DCF)
SMA 50$42.06 (Market Anchor value)
SMA 20 / Bollinger Mid$42.58
Bollinger Width / SMA2025.7% (drives anchor stability)
Net Debt$0.0B
Market Cap$1B
Peers used for multiples: ABBV, AMGN, GILD, ISRG, JNJ, LLY, MRK, UNH
60-Day Conviction
83%
20-Day Fair Value
≈ by Aug 12, 2026
$41.50
α +3.3% rank 2%
conviction
57%
40-Day Fair Value
≈ by Sep 10, 2026
$42.71
α +6.3% rank 45%
conviction
67%
60-Day Fair Value
≈ by Oct 9, 2026
$45.81
α +14.0% rank 23%
conviction
83%
MethodImplied PriceWeightDetail
DCF $0.38 23%
DDM (Gordon) n/a 0%
Peer P/E $48.30 20% median 33.1× · 8 peers
Peer EV/EBITDA $14.33 20% median 18.8× · 8 peers
Peer P/B $35.70 4% median 7.6× · 7 peers
Peer P/S $17.23 14% median 5.9× · 8 peers
Market Anchor (SMA50) $42.06 19% stability 22% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-07-14 · updated
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834) · industry map
Exchange
XNAS
Market Cap
$0.7B
Employees
14
List Date
1986-06-06
CIK
0000791908
Last Earnings
Mar 18 after close · +5.2% vs ±18.6% expected
Headquarters
Emeryville, CA
Homepage
https://www.xoma.com

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
Insufficient price history — listed 14766 days ago. Seasonality patterns need at least one full year of data.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $42.58
SMA 50: $42.06
SMA 200: $33.70
Current: $40.17
EMA 12: $42.97
EMA 26: $42.50
MACD: 0.4681 | Signal: -0.0967
BULLISH
ADX (14): 33.46
TREND
+DI: 21.89
−DI: 39.78

Momentum Oscillators

RSI (14): 34.39
NEUTRAL
Stoch %K: 58.50
Stoch %D: 80.22
Williams %R: -92.66

Volume & Volatility

BB Upper: $44.91
BB Lower: $40.25
OVERSOLD
OBV: -5,177,048
Vol SMA 20: 514,574
Vol ROC: 1427.85%
ATR: $0.91
True Range: $4.45
HV 20: 37.6%
HV 30: 31.0%
HV 60: 32.7%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-07-15T00:00:00 – 2026-07-13T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

Overall Assessment: NEUTRAL with confidence level (6/10)

Key Drivers:

  • Technical indicators suggest a moderate uptrend, with the MACD indicating bullish momentum
  • Recent news headlines have been mixed, with some negative sentiment and others being neutral or positive
  • Risk metrics indicate moderate volatility, which may not be as high-risk as other stocks in the same sector

Primary Risks:

  • Continued market uncertainty could lead to increased volatility and potential drawdowns
  • Earnings misses or guidance revisions could negatively impact the stock price

Investment Thesis:

XOMA is a moderately volatile stock with a moderate uptrend, driven by its royalty growth strategy. While there are some negative news headlines, they do not seem to be having a significant impact on the stock's movement. The options market is pricing in a relatively low volatility environment, which could lead to potential trading opportunities.

Recent News Sentiment Impact:

The recent news headlines have had a neutral-to-negative impact on the stock price, with the majority of the headlines being negative or mixed. However, the positive headline about Ligand buying XOMA for over $700 million has helped stabilize the stock's price.

Technical Analysis

Trend Direction:

  • Short-term (1-4 weeks): Uptrend
  • Medium-term (1-3 months): Moderately trending up
  • Long-term (3-12 months): Trending sideways to up

Support/Resistance Levels:

  • SMA 20: $42.58 (resistance)
  • SMA 50: $42.06 (support)
  • Bollinger Bands Upper: $44.91 (resistance)

Momentum Signals:

  • RSI: 34.39 (neutral)
  • MACD: Bullish momentum
  • Bollinger Bands: Oversold

Volume Analysis:

  • Volume SMA 20: 514574.40 (increasing volume suggests a strong trend)
  • On-Balance Volume (OBV): -5177048.73 ( bearish OBV suggests selling pressure)

News & Sentiment Analysis

Recent Headlines Summary:

The recent news headlines have been mixed, with some negative sentiment and others being neutral or positive.

Sentiment Assessment:

Aggregate news sentiment is NEUTRAL, with a mix of negative and positive headlines.

Catalyst Identification:

Upcoming events: Earnings release (no specific date provided)

Market Narrative:

The recent news headlines have not had a significant impact on the stock's movement, which suggests that market participants are waiting for more concrete catalysts before making moves. The options market is pricing in a relatively low volatility environment, which could lead to potential trading opportunities.

Risk & Volatility Assessment

Beta Interpretation:

Beta: 0.86 (vs SPY) - indicates moderate risk relative to the broader market

Volatility Regime:

Current vs historical volatility levels: Moderate volatility - stock generally follows market

Options Market Signals:

IV Rank: 13.0% (Low) - shows if volatility is historically high/low Current IV: 81.3% Expected Move: $1.52 (39 DTE), 7-DTE: $1.68

Market Context & Positioning

Sector Performance:

XOMA is a member of the Healthcare sector, which has been trending up in recent months.

Institutional Activity:

Volume patterns suggest institutional interest, with some buying and selling pressure.

Correlation Analysis:

R-squared interpretation: XOMA's price movements are moderately correlated to the broader market (0.21).

Relative Valuation:

Position within trading range: XOMA is trading near its 20-day SMA, which could be a key level of support or resistance.

Key Levels & Action Items

Critical Price Levels:

  • SMA 20: $42.58 (resistance)
  • SMA 50: $42.06 (support)

Breakout/Breakdown Levels:

  • Bollinger Bands Upper: $44.91 (resistance)

Time-Sensitive Catalysts:

Earnings release (no specific date provided)

Risk Management:

Stop-loss levels and position sizing considerations:

  • If XOMA's price breaks below SMA 50, consider taking profits or reducing exposure
  • If XOMA's price breaks above Bollinger Bands Upper, consider scaling into long positions

By analyzing the technical indicators, news headlines, and risk metrics, we can conclude that XOMA is a moderately volatile stock with a moderate uptrend. While there are some negative news headlines, they do not seem to be having a significant impact on the stock's movement. The options market is pricing in a relatively low volatility environment, which could lead to potential trading opportunities.

Generated
News
All XOMA news →
Showing 1–10 of 50
Page 1 of 5
Earnings History
12 of 12 under expected move
Avg Expected Move
20.76%
Avg Actual Move
4.07%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2023-05-09 After-Close 25.94% 2.68% 0.10x Within
2023-08-08 After-Close 32.27% 3.19% 0.10x Within
2023-11-07 After-Close 30.75% 6.15% 0.20x Within
2024-03-08 After-Close 14.77% 6.35% 0.43x Within
2024-05-09 After-Close 21.32% 7.39% 0.35x Within
2024-08-13 After-Close 18.90% 1.13% 0.06x Within
2024-11-07 Pre-Market 17.87% 6.96% 0.39x Within
2025-03-17 After-Close 24.12% 0.77% 0.03x Within
2025-05-13 After-Close 17.82% 2.73% 0.15x Within
2025-08-13 After-Close 11.49% 2.27% 0.20x Within
2025-11-12 After-Close 15.32% 4.10% 0.27x Within
2026-03-18 After-Close 18.56% 5.16% 0.28x Within

Earnings calendar: this week’s reports with expected vs actual moves →

XOMA Options Activity & IV Rank

XOMA IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 15.4%
7-DTE IV: 51.5%
Expected Move: $1.52
7-DTE Move: $1.68
Days to Exp: 39 (2026-08-21)

Options Flow · Aug 21 expiry

Call Volume: 57
Put Volume: 738
P/C Volume: 12.947
BEARISH
Call OI: 31
Put OI: 22
P/C OI: 0.71
Total OI: 53

ATM Options Pricing

ATM Call: $0.50
ATM Put: $1.02
Call %: 1.2%
Put %: 2.5%

Chain Summary

Chain Volume: 8,330
Chain OI: 7,975
Last Updated: 7/13/2026
Spread Scanner
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Scanning bull put, bear call, iron condor and calendar spreads…

Dealer Positioning
LOW γ vs HISTORY

Estimated net dealer gamma is at the 5th percentile of this name's own daily history, near the low end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
5%
vs own history
GEX tilt
-0.61
OI-weighted, today
Vanna tilt
+0.27
δ-sensitivity to IV
Charm tilt
-0.30
δ-decay vs time

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 14 ATM contracts, 7k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Jul 13 · No data
30 DTE / 10d —
— pts EXTREME
as of Jul 13 · No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Loading the implied volatility surface…

Volatility Smile

Loading the implied volatility smile…

IV Rank (7 DTE)10.2LowJul 13
IV Rank (30 DTE)2.2LowJul 13
Straddle Price (30 DTE)$1.52Jul 13
Beta Analysis
Insufficient price history — listed 14766 days ago. Beta and correlation vs SPY require ~1 year of daily returns to be statistically meaningful.
Notable investors who own XOMA
2 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Millennium Management Hedge fund
Izzy Englander
$8.3M
0.01%
#1710 of 3716-4.2%13F
Citadel Hedge fund
Ken Griffin
$1.2M
0.00%
#3477 of 6285-71.1%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

XOMA Institutional Ownership (13F)

Filings for 2026-06-30 · 1 already for 2026-09-30
Diluted shares outstanding: 17,916,250 (as of 2025-12-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

70 filers16,395,114 shares$696.66M value91.51% of float
# Filer Shares Value % of Total % of Float Period
1 BVF INC/IL 7,593,303 $322.72M 46.32% 42.38% 2026-06-30
2 Morgan Stanley Custodian 1,697,167 $72.13M 10.35% 9.47% 2026-06-30
3 FMR LLC Custodian 1,605,532 $68.24M 9.79% 8.96% 2026-06-30
4 Woodline Partners LP 1,114,363 $47.36M 6.80% 6.22% 2026-06-30
5 Newtyn Management, LLC 709,247 $30.14M 4.33% 3.96% 2026-06-30
6 BlackRock, Inc. Custodian 691,971 $29.41M 4.22% 3.86% 2026-06-30
7 Vanguard Capital Management LLC 505,165 $21.47M 3.08% 2.82% 2026-06-30
8 Opaleye Management Inc. 338,374 $14.38M 2.06% 1.89% 2026-06-30
9 WATER ISLAND CAPITAL LLC 242,000 $10.29M 1.48% 1.35% 2026-06-30
10 ALPINE ASSOCIATES MANAGEMENT INC. 239,318 $10.17M 1.46% 1.34% 2026-06-30
11 State Street Corp 197,764 $8.40M 1.21% 1.10% 2026-06-30
12 Millennium Management LLC Custodian 196,307 $8.34M 1.20% 1.10% 2026-06-30
13 HSBC Holdings plc Custodian 149,523 $6.31M 0.91% 0.83% 2026-06-30
14 Northern Trust Corp Custodian 96,179 $4.09M 0.59% 0.54% 2026-06-30
15 Vanguard Portfolio Management LLC 90,348 $3.84M 0.55% 0.50% 2026-06-30
16 TUDOR INVESTMENT CORP ET AL 84,391 $3.59M 0.51% 0.47% 2026-06-30
17 Susquehanna International Group, LLP Custodian 83,623 $3.55M 0.51% 0.47% 2026-06-30
18 TORNO CAPITAL, LLC 80,000 $3.40M 0.49% 0.45% 2026-06-30
19 Verition Fund Management LLC 70,601 $3.00M 0.43% 0.39% 2026-06-30
20 Vanguard Fiduciary Trust Co 70,189 $2.98M 0.43% 0.39% 2026-06-30
21 TLS Advisors LLC 42,165 $1.79M 0.26% 0.24% 2026-06-30
22 Two Sigma Investments, LP Custodian 36,744 $1.56M 0.22% 0.21% 2026-06-30
23 XTX Topco Ltd 35,046 $1.49M 0.21% 0.20% 2026-06-30
24 CREDIT INDUSTRIEL ET COMMERCIAL 34,853 $1.48M 0.21% 0.19% 2026-06-30
25 Balyasny Asset Management L.P. 34,621 $1.47M 0.21% 0.19% 2026-06-30
3 filers$1.16M notional
# Filer Notional Value % of Total Period
1 TORNO CAPITAL, LLC $794.75K 68.50% 2026-06-30
2 Jane Street Group, LLC Custodian $306.00K 26.37% 2026-06-30
3 CSS LLC/IL $59.50K 5.13% 2026-06-30
6 filers$9.91M notional
# Filer Notional Value % of Total Period
1 Groupe la Francaise $2.22M 22.42% 2026-06-30
2 Susquehanna International Group, LLP Custodian $2.14M 21.61% 2026-06-30
3 TORNO CAPITAL, LLC $1.74M 17.58% 2026-06-30
4 Jane Street Group, LLC Custodian $1.36M 13.77% 2026-06-30
5 Millennium Management LLC Custodian $1.28M 12.95% 2026-06-30
6 GROUP ONE TRADING LLC Custodian $1.16M 11.66% 2026-06-30

XOMA Insider Trading (Form 4)

Latest: 2026-07-16
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-07-16 BVF II GP LLC 10%+ Owner U −7,593,303 — EDGAR
2026-07-14 Jeffrey Trigilio Chief Financial Officer Other (J) −103,906 — EDGAR
2026-07-14 Maricel Perea Montano Chief Legal Officer Other (J) −42,371 — EDGAR
2026-07-14 Owen Hughes Chief Executive Officer Mixed
Disp −102,000 · Other −192,016
 −294,016 — EDGAR
2026-07-14 Heather L Franklin Director Other (J) −6,269 — EDGAR
2026-07-14 Natasha Hernday Director Mixed
Other −9,304 · Disp −4,000
 −13,304 — EDGAR
2026-07-14 Bradley Sitko Chief Investment Officer Mixed
Other −86,627 · Disp −9,440
 −96,067 — EDGAR
2026-07-14 Joseph M Limber Director Mixed
Disp −30,000 · Other −9,532
 −39,532 — EDGAR
2026-07-14 Barbara Kosacz Director Other (J) −6,269 — EDGAR
2026-07-14 Jack L Wyszomierski Director Other (J) −21,828 — EDGAR
2026-07-14 Matthew D Perry Director Other (J) −24,138 — EDGAR
2020-12-15 Matthew D Perry Director Buy (P) +200,000 $25.00 $5.00M EDGAR
2020-12-15 BVF GP HOLDINGS LLC 10%+ Owner Buy (P) +200,000 $25.00 $5.00M EDGAR
2020-11-24 Thomas M. Burns SVP, Finance & CFO Mixed
Sell −12,000 · Exer +12,000
 — $18.36 -$343.9K EDGAR
2020-11-24 James R Neal CEO Mixed
Sell −20,000 · Exer +20,000
 — $19.15 -$546.2K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

XOMA Board & Officers

As of SEC filings through Jul 16, 2026
Changes in the last 10 years (68)
Jul 16, 2026Mark N Lampert reported in an SEC filing no longer being a 10% owner
Jul 16, 2026Bvf Partners L P/il reported in an SEC filing no longer being a 10% owner
Jul 16, 2026Bvf Inc/il reported in an SEC filing no longer being a 10% owner
Jul 16, 2026Bvf II Gp LLC reported in an SEC filing no longer being a 10% owner
Jul 16, 2026Bvf I Gp LLC reported in an SEC filing no longer being a 10% owner
Jul 16, 2026Bvf Gp Holdings LLC reported in an SEC filing no longer being a 10% owner
Jul 16, 2026Biotechnology Value Fund L P reported in an SEC filing no longer being a 10% owner
Jul 16, 2026Biotechnology Value Fund II LP reported in an SEC filing no longer being a 10% owner
Jul 14, 2026Owen Hughes reported in an SEC filing no longer being a director
Jul 14, 2026Owen Hughes reported in an SEC filing no longer being Chief Executive Officer
Jul 14, 2026Natasha Hernday reported in an SEC filing no longer being a director
Jul 14, 2026Matthew D Perry reported in an SEC filing no longer being a director
Jul 14, 2026Maricel Perea Montano reported in an SEC filing no longer being Chief Legal Officer
Jul 14, 2026Joseph M Limber reported in an SEC filing no longer being a director
Jul 14, 2026Jeffrey Trigilio reported in an SEC filing no longer being Chief Financial Officer
Jul 14, 2026Jack L Wyszomierski reported in an SEC filing no longer being a director
Jul 14, 2026Heather L Franklin reported in an SEC filing no longer being a director
Jul 14, 2026Bradley Sitko reported in an SEC filing no longer being Chief Investment Officer
Jul 14, 2026Barbara Kosacz reported in an SEC filing no longer being a director
Jan 12, 2026Jeffrey Trigilio became Chief Financial Officer
Not reported recently (6)
  • Thomas M. Burns · Last reported as SVP, Finance & CFO in an SEC filing dated Sep 23, 2025
  • W Denman Van Ness · Last reported as a director in an SEC filing dated May 20, 2022
  • Deepshikha Datta · Last reported as Chief Business Officer in an SEC filing dated Feb 15, 2019
  • Peter Barton Hutt · Last reported as a director in an SEC filing dated May 22, 2017
  • John Varian · Last reported as a director in an SEC filing dated May 22, 2017
  • Timothy P Walbert · Last reported as a director in an SEC filing dated May 22, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
4 ETFs hold XOMA
4 shown · $487.76K total exposure
# ETF Provider Weight $ Exposure ETF AUM As Of
1 EES WisdomTree U.S. SmallCap Fund Nport 0.04% $319,898 — 2026-06-30
2 EVNT AltShares Event-Driven ETF Nport 1.01% $123,879 — 2026-05-31
3 LITL Simplify Piper Sandler US Small-Cap PLUS Income ETF Nport 0.63% $43,138 — 2026-06-30
4 RESM Columbia Research Enhanced Small Cap ETF Nport 0.02% $850 — 2026-06-30
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$1.46
TTM Revenue
$52.15M
TTM Net Income
$18.53M
TTM Op. Cash Flow
$2.87M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q4 '252025-12-31$13.76M$3.32M$0.26$-5.50M
Q3 '252025-09-30$9.35M$8.98M$0.70$-296.00K
Q2 '252025-06-30$13.13M$5.52M$0.44$6.47M
Q1 '252025-03-31$15.91M$705.00K$0.06$2.20M
Q4 '242024-12-31$8.71M$-5.34M$-0.45$-2.90M
Q3 '242024-09-30$7.20M$-18.61M$-1.59$-8.62M
Q2 '242024-06-30$11.09M$10.22M$0.84$2.73M
Q1 '242024-03-31$1.49M$-9.96M$-0.86$-4.95M
Q4 '232023-12-31$1.83M$-21.48M$-1.87$-3.93M
Q3 '232023-09-30$830.00K$-6.88M$-0.60$-2.10M
Q2 '232023-06-30$1.66M$-6.77M$-0.59$-7.21M
Q1 '232023-03-31$437.00K$-11.18M$-0.98$-4.92M
Q4 2025 • period ending 2025-12-31 • filed 2026-03-18
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
0.00
P/B
—
P/S
—
EV/EBITDA
—
EV/Sales
—
ROE
22.1%
ROA
6.8%
Div Yield
0.78%
FCF Yield
—
Debt/Equity
1.15
Current Ratio
—
Market Cap
$0.00
as of 2026-07-14

XOMA vs Peers

Related companies, largest first
Company Market cap P/E Revenue growth YTD IV rank
PEN Penumbra, Inc. $12.6B 80.9 +17.0% +3.8% 26
AMRX Amneal Pharmaceuticals, Inc. Class A Com $7.0B 43.4 +9.3% +68.0% 33
CNTA Centessa Pharmaceuticals plc American De $6.3B — — +71.0% —
CPRX Catalyst Pharmaceutical Inc. $3.9B 18.1 +11.7% +36.0% —
OGN Organon & Co. $3.6B 18.0 −3.2% +91.6% 19
KALV KalVista Pharmaceuticals, Inc. Common St $1.4B — — +74.6% —
AVNS Avanos Medical, Inc. $1.2B — +3.9% +123.5% —
XOMA XOMA Royalty Corporation Common Stock $710M 27.5 +83.1% +43.5% —
AURA Aura Biosciences, Inc. Common Stock $680M — — +42.5% 19
Peer median $3.7B 30.8 +9.3% +69.5% 22

P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.

Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
914.94K
SI % of Float
7.51%
Days to Cover
5.04
Short Vol Ratio
67.4%
Free Float
12.19M
Float %
98.4%
Short interest 2026-06-30 • Short volume 2026-07-13 • Float 2026-03-06